CYNTHIA ROJAS: Open Payments
NPI 1093162562 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 18 payments from 9 companies in 2025. Trend: 2023 $157 · 2024 $454 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $144 |
| GENZYME CORPORATION | 2 | $53 |
| Amgen Inc. | 3 | $49 |
| Organon LLC | 2 | $35 |
| Galderma Laboratories, L.P. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: Bimzelx, DUPIXENT, Otezla, VTAMA, NEMLUVIO, Zoryve, TREMFYA, COSENTYX.
Industry payments across CA — which companies pay providers there.
